BackCipher Pharmaceuticals Overview

Cipher Pharmaceuticals Operating Income

Operating Income for CPHRF.

Quarterly Operating Income

$5.52M
123.02% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$19.75M
286.29% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)